M. J. Manco‐Johnson

Author

M. J. Manco‐Johnson

Also Known As

M. J. MANCO‐JOHNSON, M. J. Manco-Johnson, M. J. Manco‐Johnson, M.J. Manco-Johnson, Michael Manco-Johnson, Michael Manco–Johnson

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

University of Colorado Denver Hospital for Sick Children University of Colorado Health Center for Cancer and Blood Disorders Indiana Hemophilia and Thrombosis Center

About

M. J. Manco‐Johnson is an author at University of Colorado Denver specializing in medicine, hematology, and pediatrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	699
2	Epidemiology	2	2	89
3	Public Health	1	1	67
4	Emergency Medicine	1	1	270
5	Immunology	1	1	22

M. J. Manco‐Johnson

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
von Willebrand disease (VWD): evidence‐based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA) <sup>1</sup> William L. Nichols, MB Hultin, Allison James, Haemophilia	2008	947
Consensus perspectives on prophylactic therapy for haemophilia: summary statement Erik Berntorp, Jan Astermark, Sven Björkman, Haemophilia Consensus SummaryPreventive MedicineSecondary ProphylaxisHealthcare-associated InfectionHematology	2003	270
Renal structure and hypertension in autosomal dominant polycystic kidney disease Patricia A. Gabow, Arlene B. Chapman, Margaret Johnson, Kidney International GlomerulonephritisHypertensionUrologyRenal DiseaseRenal Structure	1990	224
Autosomal dominant polycystic kidney disease in childhood: A longitudinal study Aileen B. Sedman, Patricia Bell, M. J. Manco‐Johnson, Kidney International GlomerulonephritisUrologyMedicineKidney FailureRenal Pathology	1987	152
An MRI scale for assessment of haemophilic arthropathy from the International Prophylaxis Study Group Björn Lundin, M L Manco-Johnson, Danial M. Ignas, Haemophilia	2012	141
A survey of factor prophylaxis in boys with haemophilia followed in North American haemophilia treatment centres Victor S. Blanchette, M. Mccready, Camille Achonu, Haemophilia Factor Prophylaxis UsePopulation ChildrenEpidemiologyClinical EpidemiologyHematology	2003	67
Consequences of switching from prophylactic treatment to on‐demand treatment in late teens and early adults with severe haemophilia A: the TEEN/TWEN study M. J. Manco‐Johnson, J. Sanders, Nadia P. Ewing, Haemophilia	2013	29
Influence of factor VIII on overall coagulability and fibrinolytic potential of haemophilic plasma as measured by global assay: monitoring in haemophilia A Neil A. Goldenberg, William E. Hathaway, Linda Jacobson, Haemophilia Coagulation IndexHealthy SubjectsImmunologyPathologyInflammation	2006	22
Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations Brian Boylan, A. Rice, Christine De Staercke, Journal of Thrombosis and Haemostasis Hemophilia A PatientsGenetic DisorderGeneticsPathogenesisGenetic Epidemiology	2015	18
Primary Antiphospholipid Antibody Syndrome and Cardiac Involvement in a Child Sarah Clauss, M. J. Manco‐Johnson, Eric S. Quivers, Pediatric Cardiology Heart FailureCardiovascular DiseasePediatric Heart DiseaseCardiac InvolvementPediatrics	2003	13

Page 1